Reports
Sale
Global Gastric Ulcer Treatment Market Share, Size, Analysis, Trends, Growth: By Drug Class: Antacids, Anti-Histamines, Antibiotics, H2 Receptor Antagonist, Proton Pump Inhibitor (PPIs); By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Others; Regional Analysis; Competitive Landscape; Industry Events and Developments; 2024-2032
Global Gastric Ulcer Treatment Market Outlook
The global gastric ulcer treatment market is estimated to grow at a CAGR of 2.80% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market for Gastric Ulcer Treatment Witnessing Increased Demand for Antibiotics
There is a growing demand for antibiotics to treat gastric ulcers. The rising incidence of gastric ulcers, caused by a combination of an H. pylori infection and taking non-inflammatory medicines (NSAIDs), is leading to the recommendation for triple therapy, which combines two antibiotics and a proton pump inhibitor.
Additionally, antibiotics are increasingly used in other treatments, like quadruple therapy and sequential therapy, thereby aiding the gastric ulcer treatment market. There is a rising inclination of doctors towards prescribing antibiotics in place of the traditional antacids, owing to the growing awareness about the bacterium called Helicobacter pylori that causes gastric ulcers. The chances of gastric ulcers recurring after taking antacids are higher, which is leading to the increased preference for antibiotics. Several antibiotics, such as amoxicillin, clarithromycin, and metronidazole are available in the market.
Market Segmentation
Gastric ulcers are inflammation in the stomach or small intestine lining, which occurs when the protective mucus lining of the stomach loses its effectiveness. The strong acid produced by the stomach damages the stomach tissue, which leads to ulcers. The causes of gastric ulcers are H. pylori bacteria and nonsteroidal anti-inflammatory drugs. The different treatments include antibiotics, proton pump inhibitors, antacids, and H2 receptor antagonists, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The gastric ulcer treatment market, by drug class, is divided into:
- Antacids
- Anti-Histamines
- Antibiotics
- H2 Receptor Antagonist
- Proton Pump Inhibitor (PPIs)
On the basis of distribution channel, the market is classified into:
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
The regional markets for gastric ulcer treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Increasing Prevalence of Gastric Ulcer Disease to Drive the Demand for its Treatment
Factors like the growing prevalence of gastric ulcers, expanding geriatric population, and the growing awareness about the treatment options are contributing to the gastric ulcer treatment market growth. The market is being supported by the developing healthcare infrastructure, improving diagnostic facilities, and improved living standards. Further, the emergence of online pharmacies and the easy availability of medications, coupled with ease and convenience offered by online services are invigorating the market.
The initiatives taken by pharmaceutical companies for developing new drugs for the effective treatment of gastric ulcer are bolstering the market. In December 2021, the FDA approved glycopyrrolate orally disintegrating tablets to reduce the symptoms of peptic ulcers. The research and development activities and the rising conduction of clinical trials for new drug development are expected to further support the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Players in the Global Gastric Ulcer Treatment Market
The report gives a detailed analysis of the following key players in the market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- AstraZeneca PLC
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Nuvo Pharmaceuticals Inc. (Aralez Pharmaceuticals)
- Daiichi Sankyo Company, Limited
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Gastric Ulcer Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Gastric Ulcer Treatment Historical Market (2018-2023)
8.3 Global Gastric Ulcer Treatment Market Forecast (2024-2032)
8.4 Global Gastric Ulcer Treatment Market by Drug Class
8.4.1 Antacids
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Anti-Histamines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Antibiotics
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 H2 Receptor Antagonist
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.5 Proton Pump Inhibitor (PPIs)
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2023)
8.4.5.3 Forecast Trend (2024-2032)
8.5 Global Gastric Ulcer Treatment Market by Distribution Channel
8.5.1 Retail Pharmacy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Hospital Pharmacy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Online Pharmacy
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Others
8.6 Global Gastric Ulcer Treatment Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 AstraZeneca PLC
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Takeda Pharmaceutical Company Limited
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Boehringer Ingelheim International GmbH
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Nuvo Pharmaceuticals Inc. (Aralez Pharmaceuticals)
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Daiichi Sankyo Company, Limited
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Gastric Ulcer Treatment Market: Key Industry Highlights, 2017 and 2021
2. Global Gastric Ulcer Treatment Historical Market: Breakup by Drug Class (USD Million), 2018-2023
3. Global Gastric Ulcer Treatment Market Forecast: Breakup by Drug Class (USD Million), 2024-2032
4. Global Gastric Ulcer Treatment Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
5. Global Gastric Ulcer Treatment Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
6. Global Gastric Ulcer Treatment Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Gastric Ulcer Treatment Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Gastric Ulcer Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Gastric Ulcer Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Gastric Ulcer Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Gastric Ulcer Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Gastric Ulcer Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Gastric Ulcer Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Gastric Ulcer Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Gastric Ulcer Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Gastric Ulcer Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Gastric Ulcer Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Gastric Ulcer Treatment Market Structure
Key Questions Answered in the Report
The global gastric ulcer treatment market is assessed to grow at a CAGR of 2.80% between 2024 and 2032.
The major market drivers include the growing geriatric population, improved living standards, rising diagnosis of the disease, expanding distribution channels, rising intake of antibiotics to treat the disease, and growing awareness about the treatment options.
What are the key factors influencing the global gastric ulcer treatment market growth opportunities?
The key market trends guiding the growth of the market include the increasing prevalence of gastric ulcer disease, developing healthcare infrastructure, government initiatives, research and development activities, and efforts taken by market players to develop new drugs.
Gastric ulcer is formed by the breaking down of the stomach’s lining due to Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs.
The significant drug classes of gastric ulcer treatment include antacids, anti-histamines, antibiotics, H2 receptor antagonist, and proton pump inhibitor (PPIs).
The different distribution channels of gastric ulcer treatment include retail pharmacy, hospital pharmacy, and online pharmacy, among others.
The major players in the market are AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Nuvo Pharmaceuticals Inc. (Aralez Pharmaceuticals), and Daiichi Sankyo Company, Limited, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER